Thank you for the reply, Thomas.
All of the current due diligence and vetting being done probably doesn't mean much to those poor investors who got duped by Robinson and lost 160 grand in 2010. As any student of psychology can tell you, "the most trustworthy indicator of future behavior is past behavior."
The handling of the OTCQX de-listing has raised even more red flags. I have reached out to the OTC Markets Group for their comments on this, however I have not gotten any worthwhile responses. And to be honest, it's not their job to give them to me - it's the CEO of Predictive Technology's job.
As a publicly traded company, it is the absolute responsibility of the company to inform its shareholders the details of an event like getting removed from a financial market.
The press release given by the CEO was garbage, and confirmed that PRED was doing something that the OTC Markets Group deemed serious enough to de-list them. If a mistake was made, take responsibility and let the investors know what happened, and give them an idea on what action you are taking to resolve it. Instead, we are given nothing, and are expected to believe that a Nasdaq uplisting is "just around the corner" when we couldn't last on the OTCQX for a week.
While we've all heard rumors of 'huge press releases, deals, and partnerships looming' over the past year, nothing valuable of the sort has been announced. Is it because the company is waiting for a Nasdaq uplist, or is it because (as I suspect) there simply is nothing worthwhile to announce?
Again, despite these warning signs, PRED seems to be building bridges into the international market, which potentially means big money within a year or two. Assuming that the diagnostic products are successful, PRED can be a rockstar for us all - let's just hope they start being a little more transparent!